ArticlePolymers2021
Properties Enhancement of High Molecular Weight Polylactide Using Stereocomplex Polylactide as a Nucleating Agent.
Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 22 citations in OpenAlex.
- Review
- Article
- Development of Stereocomplex Polylactide Nanocomposites as an Advanced Class of Biomaterials-A Review.Polymers · 2023Review
- Article
- Enhancement in Crystallizability of Poly(Polymers · 2022Article
- Effects on the crystallization behavior and biocompatibility of poly(LLA-ran-PDO-ran-GA) with poly(d-lactide) as nucleating agents.RSC advances · 2022Article
- Biodegradable membrane of poly(l-lactide acid-dioxanone-glycolide) and stereocomplex poly(lactide) with enhanced crystallization and biocompatibility.Frontiers in bioengineering and biotechnology · 2022Article
- Novel Poly(Methylenelactide-Polymers · 2021Article
- The Effect of Stereocomplex Polylactide Particles on the Stereocomplexation of High Molecular Weight Polylactide Blends.Polymers · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
As one of the most attractive biopolymers nowadays in terms of their sustainability, degradability, and material tune-ability, the improvement of polylactide (PLA) homopolymer properties by studying the utilization of stereocomplex polylactide (s-PLA) effectively and efficiently is needed. In this sense, we have studied the utilization of s-PLA compared to poly D-lactide (PDLA) homopolymers as a nucleating agent for PLA homopolymers. The mechanical and thermal properties and crystallization behavior of PLA homopolymers in the presence of nucleating agents have been evaluated using a universal testing machine, differential scanning calorimeter, and X-ray diffractometer instruments, respectively. PDLA and s-PLA materials can be used to increase the thermal and mechanical properties of poly L-lactide (PLLA) homopolymers. The s-PLA materials increased the mechanical properties by increasing crystallinity of the PLLA homopolymers. PLLA/s-PLA enhanced mechanical properties to a certain level (5% s-PLA content), then decreased them due to higher s-PLA materials affecting the brittleness of the blends. PDLA homopolymers increased mechanical properties by forming stereocomplex PLA with PLLA homopolymers. Non-isothermal and isothermal evaluation showed that s-PLA materials were more effective at enhancing PLLA homopolymer properties through nucleating agent mechanism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.